Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research
$199.00
Comprar en Amazon Ver en Apple Books¿Lo prefieres en papel? Todos los formatos en Amazon →
Precio en Apple Books. En Amazon puede ser otro.
- Publicado
Descripción
Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research.